Subject: Re: Benchmark Investing Update Dec 26, 2025
With this week's update Jan. 30, 2026

SELL: EPAM limited upside potential compared to the overall market. Held this stock 451 days.
The market returned about 19% since entry and EPAM returned nearly +31% (including dividends.

ADD: CRM continues to meet all buy requirements. BI Downside target -58%.